Shi Gao Liu
Plus aucun poste en cours
Fortune : 4 M $ au 31/03/2024
Historique de carrière de Shi Gao Liu
Anciens postes connus de Shi Gao Liu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Director/Board Member | - | 30/09/2020 |
| Chief Executive Officer | 01/12/2009 | 30/09/2020 | |
| Founder | 01/12/2009 | 30/09/2020 | |
| President | 01/12/2009 | 19/02/2020 | |
Henlius Biopharmaceuticals, Inc.
 Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Chief Executive Officer | 01/01/2009 | - |
| Founder | 01/01/2009 | - | |
| President | 01/01/2009 | - |
Formation de Shi Gao Liu
| Purdue University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Chine | 2 |
Opérationnelle
| Chief Executive Officer | 2 |
| Founder | 2 |
| President | 2 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Health Technology |
- Bourse
- Insiders
- Shi Gao Liu
- Expérience
